Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Drug for preventing and auxiliarily treating cardiovascular and cerebrovascular diseases

A cardiovascular and cerebrovascular disease and drug technology, applied in the field of preventive and auxiliary drugs, can solve the problems of high morbidity and mortality of cardiovascular and cerebrovascular diseases, substandard control of various indicators, and inconvenient taking, etc. Diabetes and heart and brain diseases, prevention and adjuvant treatment of obesity, low cost of raw materials

Inactive Publication Date: 2019-03-22
杜明华
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current treatment method is to control a single factor such as lowering blood pressure or blood sugar or lipid or inhibiting platelet activity, or to control several factors at the same time. , inconvenient to take, easy to miss doses, substandard control of various indicators, high cost, large side effects, high morbidity and mortality of cardiovascular and cerebrovascular diseases, causing great economic burden and pain to society, families and individuals

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0025] The embodiment of the invention discloses a preventive and auxiliary medicine for cardiovascular and cerebrovascular diseases, which has the characteristics of non-toxicity, no side effect, simple preparation method, convenient consumption and low cost.

[0026] Please refer to the preventive and auxiliary medicine for cardiovascular and cerebrovascular diseases disclosed in the present invention, which specifically includes:

[0027] Pueraria 4g, Angelica dahurica 3g,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for preventing and auxiliarily treating cardiovascular and cerebrovascular diseases. The drug is characterized by being prepared from the following raw materials: 4 g ofradix puerariae, 3 g of radix angelicae dahuricae, 4 g of fructus crataegi, 3 g of cordyceps militaris, 4 g of rhizoma polygonati odorati, 4 g of black soybean, 4 g of spica prunellae, 4 g of foliumnelumbinis, 4 g of fructus hippophae, 3 g of rhizoma polygonati, 3 g of fructus mume, 3 g of rhizoma dioscoreae, 3 g of semen ziziphi spinosae, 3 g of sharpleaf galangal fruit, 3 g of radix ginseng, 3g of walnut kernel, 3 g of pine nut, 3 g of folium mori, 3 g of bulbus lilii, 3 g of semen cassiae, 2 g of flos sophorae immaturus, 2 g of flos sophorae, 2 g of herba taraxaci, 2 g of semen coicis, 2g of semen raphani, 2 g of fructus citri sarcodactylis, 2 g of ginkgo, 2 g of deer heart, 2 g of flos chrysanthemi, 2 g of cortex cinnamomi, 1 g of shiitake, 1 g of radix glycyrrhizae, 1 g of black fungus, 1 g of Tremella fuciformis, 1 g of young barley grass, 1 g of allium macrostemon, 1 g of rape pollen, 1 g of pine pollen, 1 g of buckwheat pollen, 1 g of rose, 1 g of corn oligopeptide and 1 gof spirulina maxima. The raw materials have low cost, the processing technology is simple, and the drug has good preventing and auxiliarily treating effects on the cardiovascular and cerebrovascular diseases.

Description

technical field [0001] The invention relates to the technical field of solid beverages, and more specifically relates to a preventive and auxiliary medicine for cardiovascular and cerebrovascular diseases. Background technique [0002] Cardiovascular and cerebrovascular diseases have become the number one killer of human health, and its mortality rate accounts for 52% of the total mortality rate. A large number of sub-healthy people are about to develop cardiovascular and cerebrovascular diseases. A large number of evidence-based medical studies at home and abroad have confirmed that the etiology of cardiovascular and cerebrovascular diseases is multifactorial, and some factors are uncontrollable, such as age, gender, genetics, race, etc. The older the age, the higher the risk factor, and the risk factor is higher for men than women , the incidence is also directly related to genetics and race; the main pathogenic factors that can be controlled are hypertension, hyperlipidem...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L2/39A23L2/52A23L33/10A23L33/105A23L33/135A23L33/17A61K38/01A61P3/04A61P3/10A61P9/00A61P9/10A61K36/9062A61K35/34A61K35/748
CPCA61K36/8945A61K36/8962A61K36/8967A61K36/8969A61K36/8994A61K36/8998A61K36/9062A61K38/011A61P3/04A61P3/10A61P9/00A61P9/10A23L2/39A23L2/52A23L33/10A23L33/105A23L33/135A23L33/17A61K9/0095A61K35/34A61K35/748A61K36/068A61K36/07A61K36/15A61K36/16A61K36/185A61K36/232A61K36/258A61K36/287A61K36/288A61K36/31A61K36/48A61K36/482A61K36/484A61K36/488A61K36/489A61K36/52A61K36/536A61K36/54A61K36/605A61K36/62A61K36/70A61K36/725A61K36/734A61K36/736A61K36/738A61K36/752A23V2002/00A61K2300/00A23V2200/328A23V2200/326A23V2200/332A23V2250/21A23V2250/204A23V2250/206A23V2250/208A23V2250/2122A23V2250/2124
Inventor 杜明华
Owner 杜明华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products